个人简介： 2017年博士毕业于中国农业大学临床兽医系，博士期间受国家留学基金委资助于2015-2016年赴加拿大University of Calgary动物医学院联合培养，毕业后进入中国农业大学动物营养国家重点实验室从事博士后研究工作，2019年出站后留校任临床兽医系讲师。参与讲授本科生“现代兽医影像技术概论”和“兽医放射学”等课程。 代表性文章： 1. Gang Liu, Jinhua Yin, Bo Han, Herman W. Barkema, Muhammad Shahid, Jeroen De Buck, Eduardo Cobo, John Kastelic, Jian Gao. Adherent/invasive capacities of bovine-associated Aerococcus viridans contribute to pathogenesis of acute mastitis in a murine model. Veterinary Microbiology, 2019, (230): 201-211. 2. Gang Liu, Tariq Ali, Jian Gao, Sadeeq ur Rahman, Dan Yu, Herman W. Barkema, Wenlin Huo, Siyu Xu, Yuxiang Shi, John P. Kastelic, Bo Han. Co-occurrence of plasmid-mediated colistin resistance (mcr-1) and extended-spectrum β-lactamase encoding genes in Escherichia coli from bovine mastitic milk in China. Microbial Drug Resistance. 2019. DOI:10.1089/mdr.2019.0333. 3. Gang Liu, Laiding Ding, Bo Han, Piepers Sofie, Naqvi Syed Ali, Barkema Herman, Ali Taliq, De Vliegher, Xu Siyu, Jian Gao. Characteristics of Escherichia coli isolated from bovine mastitis exposed to subminimum inhibitory concentrations of cefalotin or ceftazidime. Biomed Research International, 2018:4301628. 4. Gang Liu, Jinhua Yin, Herman W. Barkema, Liben Chen, Muhammad Shahid, Otto Szenci, Jeroen De Buck, John P. Kastelic, Bo Han. Development of a single-dose recombinant CAMP factor entrapping poly (lactide-co-glycolide) microspheres-based vaccine against Streptococcus agalactiae. Vaccine, 2017, 35(9):1246-1253. 5. Gang Liu, Yongxia Liu, Rashad Alkasir, Mohammad Zahra, Tariq Ali, Miro Ferreri, Jian Gao, Zhaoju Deng, Wei Chen, Jinhua Yin, Bo Han. Molecular and phenotypic characterization of Aerococcus viridans associated with subclinical bovine mastitis in Northern China. PloS ONE, 2015, 10(4): e0125001. 6. Yongxia Liu, Gang Liu*, Wenjun Liu, Yong Liu, Tariq Ali, Wei Chen, Jinhua Yin, Bo Han. Phylogenetic group, virulence genotype, antimicrobial resistance and associated genes of mastitis Escherichia coli isolated from Beijing, China. Research in Microbiology, 2014, 165:273-277. *Equal contribution |
